FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Linenberger

Research Profile

Living Beings

Disorders

Anatomy

Physiology

Haematopoiesis

Chemicals & Drugs

Procedures

Blood Component Removal

Co-author Network

Publications

TOP 3
Bart L Scott; Mohamed L Sorror; Rainer Storb; Frederick R Appelbaum; Veronika Buxhofer-Ausch; Thomas R Chauncey; Theodore A Gooley; Jonathan Grim; Michael L Linenberger; David Myerson; Jerald P Radich; Andrew R Rezvani; Brenda M Sandmaier; H Joachim Deeg
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
Zbigniew M Szczepiorkowski; Jeffrey L Winters; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Robert Weinstein; Beth H Shaz
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
Karim Valji; Michael L Linenberger
Chasing clot: thrombophilic states and the interventionalist.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Linenberger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Bart L Scott; Mohamed L Sorror; Rainer Storb; Frederick R Appelbaum; Veronika Buxhofer-Ausch; Thomas R Chauncey; Theodore A Gooley; Jonathan Grim; Michael L Linenberger; David Myerson; Jerald P Radich; Andrew R Rezvani; Brenda M Sandmaier; H Joachim Deeg
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
Blood 2012;119(11):2657-64.
2010: Zbigniew M Szczepiorkowski; Jeffrey L Winters; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Robert Weinstein; Beth H Shaz
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
Journal of clinical apheresis 2010;25(3):83-177.
2009: Karim Valji; Michael L Linenberger
Chasing clot: thrombophilic states and the interventionalist.
Journal of vascular and interventional radiology : JVIR 2009;20(11):1403-16; quiz 1417.
2008: Lawrence D Wagman; Melissa F Baird; Charles L Bennett; Paula L Bockenstedt; Spero R Cataland; John Fanikos; Patrick F Fogarty; Samuel Z Goldhaber; Tejpal S Grover; William Haire; Hani Hassoun; Suzanne Hutchinson; Mohammad Jahanzeb; Jason Lee; Michael L Linenberger; Michael M Millenson; Thomas L Ortel; Riad Salem; Judy L Smith; Michael B Streiff; Suresh Vedantham
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(8):716-53.
2007: Zbigniew M Szczepiorkowski; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Beth H Shaz; Robert Weinstein; Ashka Wirk; Jeffrey L Winters
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
Journal of clinical apheresis 2007;22(3):106-75.
2007: Beth H Shaz; Michael L Linenberger; Nicholas Bandarenko; Jeffrey L Winters; Haewon C Kim; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Robert Weinstein; Ashka Wirk; Zbigniew M Szczepiorkowski
Category IV indications for therapeutic apheresis: ASFA fourth special issue.
Journal of clinical apheresis 2007;22(3):176-80.
2006: Michael L Linenberger
Catheter-related thrombosis: risks, diagnosis, and management.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(9):889-901.
2006: Lawrence D Wagman; Melissa F Baird; Charles L Bennett; Paula L Bockenstedt; Spero R Cataland; John Fanikos; Patrick F Fogarty; Samuel Z Goldhaber; Tejpal S Grover; William Haire; Hani Hassoun; Mohammad Jahanzeb; Lawrence L Leung; Michael L Linenberger; Michael Millenson; Thomas L Ortel; Riad Salem; Judy L Smith; Michael B Streiff
Venous thromboembolic disease. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(9):838-69.
2005: Michael L Linenberger; Ann K Wittkowsky
Thromboembolic complications of malignancy. Part 2: management.
Oncology (Williston Park, N.Y.) 2005;19(8):1077-84; discussion 1084, 1087-8.
2005: Michael L Linenberger; Ann K Wittkowsky
Thromboembolic complications of malignancy. Part 1: Risks.
Oncology (Williston Park, N.Y.) 2005;19(7):853-61.
2005: Michael L Linenberger; Thomas H Price
Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.
Journal of intensive care medicine 2005;20(2):88-103.
2005: Michael L Linenberger
CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance.
Leukemia 2005;19(2):176-82.
2005: Michael L Linenberger; Thomas H Price
Use of cellular and plasma apheresis in the critically ill patient: part 1: technical and physiological considerations.
Journal of intensive care medicine 2005;20(1):18-27.
2004: Roland B Walter; Brian W Raden; J Thompson; David A Flowers; H-P Kiem; Irwin D Bernstein; Michael L Linenberger
Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells.
Leukemia 2004;18(11):1914-7.
2003: Roland B Walter; Brian W Raden; Tom C Hong; David A Flowers; Irwin D Bernstein; Michael L Linenberger
Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.
Blood 2003;102(4):1466-73.
2002: Alexander P Reiner; Michele B Frank; Stephen M Schwartz; Michael L Linenberger; William T Longstreth; Gayle Teramura; Frits R Rosendaal; Bruce M Psaty; David S Siscovick
Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.
British journal of haematology 2002;116(2):376-82.
2002: Michael L Linenberger; David G Maloney; Irwin D Bernstein
Antibody-directed therapies for hematological malignancies.
Trends in molecular medicine 2002;8(2):69-76.
2001: Eric L Sievers; Michael L Linenberger
Mylotarg: antibody-targeted chemotherapy comes of age.
Current opinion in oncology 2001;13(6):522-7.
2001: Michael L Linenberger; T Hong; David A Flowers; Eric L Sievers; Theodore A Gooley; John M Bennett; Mark S Berger; Lance H Leopold; Frederick R Appelbaum; Irwin D Bernstein
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.
Blood 2001;98(4):988-94.
2000: Michael L Linenberger; J Kindelan; R L Bennett; Alexander P Reiner; H C Côté
Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family.
American journal of hematology 2000;64(4):242-50.
1999: Michael L Linenberger; T Deng
The effects of feline retroviruses on cytokine expression.
Veterinary immunology and immunopathology 1999;72(3-4):343-68.
1999: Michael L Linenberger; JL Rohn; T Deng; S Ellis-Smith; R Ingber; Julie Overbaugh
Lymphokines modulate the growth and survival of thymic tumor cells containing a novel feline leukemia virus/Notch2 variant.
Veterinary immunology and immunopathology 1999;70(3-4):223-43.
1999: Scott M Schuetze; Michael L Linenberger
Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant.
Transplantation 1999;67(10):1366-9.
1996: J L Rohn; S R Gwynn; A S Lauring; Michael L Linenberger; Julie Overbaugh
Viral genetic variation, AIDS, and the multistep nature of carcinogenesis: the feline leukemia virus model.
Leukemia 1996;10(12):1867-9.
1996: J L Rohn; A S Lauring; Michael L Linenberger; Julie Overbaugh
Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.
Journal of virology 1996;70(11):8071-80.
1996: Sharon A Dobie; Allan J Ellsworth; Michael L Linenberger
Treatment of a patient with an undefined hypercoagulable state with long-term low-molecular-weight heparin.
The Western journal of medicine 1996;164(4):350-3.
1995: G H Shelton; Michael L Linenberger
Hematologic abnormalities associated with retroviral infections in the cat.
Seminars in veterinary medicine and surgery (small animal) 1995;10(4):220-33.
1995: Michael L Linenberger; S W Dow; Janis L Abkowitz
Feline leukemia virus infection downmodulates the production of growth-inhibitory activity by marrow stromal cells.
Experimental hematology 1995;23(10):1069-79.
1995: Michael L Linenberger; F W Jacobson; L G Bennett; Virginia C Broudy; F H Martin; Janis L Abkowitz
Stem cell factor production by human marrow stromal fibroblasts.
Experimental hematology 1995;23(10):1104-14.
1995: G H Shelton; Michael L Linenberger; M T Persik; Janis L Abkowitz
Prospective hematologic and clinicopathologic study of asymptomatic cats with naturally acquired feline immunodeficiency virus infection.
Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 1995;9(3):133-40.
1995: Michael L Linenberger; Janis L Abkowitz
Haematological disorders associated with feline retrovirus infections.
Baillière's clinical haematology 1995;8(1):73-112.
1995: Michael L Linenberger; A M Beebe; Niels C Pedersen; Janis L Abkowitz; Satya Dandekar
Marrow accessory cell infection and alterations in hematopoiesis accompany severe neutropenia during experimental acute infection with feline immunodeficiency virus.
Blood 1995;85(4):941-51.
1994: J L Rohn; Michael L Linenberger; Edward A Hoover; Julie Overbaugh
Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors.
Journal of virology 1994;68(4):2458-67.
1993: Janis L Abkowitz; Michael L Linenberger; M Persik; M A Newton; Peter Guttorp
Behavior of feline hematopoietic stem cells years after busulfan exposure.
Blood 1993;82(7):2096-103.
1992: Michael L Linenberger; Janis L Abkowitz
In vivo infection of marrow stromal fibroblasts by feline leukemia virus.
Experimental hematology 1992;20(8):1022-7.
1992: Michael L Linenberger; Janis L Abkowitz
Studies in feline long-term marrow culture: hematopoiesis on normal and feline leukemia virus infected stromal cells.
Blood 1992;80(3):651-62.
1991: G H Shelton; Michael L Linenberger; Janis L Abkowitz
Hematologic abnormalities in cats seropositive for feline immunodeficiency virus.
Journal of the American Veterinary Medical Association 1991;199(10):1353-7.
1991: Michael L Linenberger; G H Shelton; M T Persik; Janis L Abkowitz
Hematopoiesis in asymptomatic cats infected with feline immunodeficiency virus.
Blood 1991;78(8):1963-8.
1990: Janis L Abkowitz; Michael L Linenberger; M A Newton; G H Shelton; R L Ott; Peter Guttorp
Evidence for the maintenance of hematopoiesis in a large animal by the sequential activation of stem-cell clones.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(22):9062-6.
1990: G H Shelton; C K Grant; Michael L Linenberger; Janis L Abkowitz
Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection.
Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 1990;4(6):317-9.
1990: G H Shelton; Michael L Linenberger; C K Grant; Janis L Abkowitz
Hematologic manifestations of feline immunodeficiency virus infection.
Blood 1990;76(6):1104-9.
1989: G H Shelton; Janis L Abkowitz; Michael L Linenberger; R G Russell; C K Grant
Chronic leukopenia associated with feline immunodeficiency virus infection in a cat.
Journal of the American Veterinary Medical Association 1989;194(2):253-5.